These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37009042)
21. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management. Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176 [TBL] [Abstract][Full Text] [Related]
22. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. Jayasooriya AP; Sakono M; Yukizaki C; Kawano M; Yamamoto K; Fukuda N J Ethnopharmacol; 2000 Sep; 72(1-2):331-6. PubMed ID: 10967491 [TBL] [Abstract][Full Text] [Related]
23. Diverse roles of bitter melon ( Sur S; Ray RB J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34765739 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon ( Hussain L; Aamir N; Hussain M; Asif M; Chauhdary Z; Manzoor F; Siddique R; Riaz M Evid Based Complement Alternat Med; 2022; 2022():5143653. PubMed ID: 36212951 [TBL] [Abstract][Full Text] [Related]
26. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats. Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon. Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022 [TBL] [Abstract][Full Text] [Related]
28. Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium. Czompa A; Gyongyosi A; Szoke K; Bak I; Csepanyi E; Haines DD; Tosaki A; Lekli I Molecules; 2017 Mar; 22(3):. PubMed ID: 28335529 [No Abstract] [Full Text] [Related]
29. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Efird JT; Choi YM; Davies SW; Mehra S; Anderson EJ; Katunga LA Int J Environ Res Public Health; 2014 Feb; 11(2):2328-45. PubMed ID: 24566057 [TBL] [Abstract][Full Text] [Related]
30. Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study. Kinoshita H; Ogata Y Evid Based Complement Alternat Med; 2018; 2018():4915784. PubMed ID: 30532795 [TBL] [Abstract][Full Text] [Related]
31. Bortolotti M; Mercatelli D; Polito L Front Pharmacol; 2019; 10():486. PubMed ID: 31139079 [No Abstract] [Full Text] [Related]
32. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products. Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408 [TBL] [Abstract][Full Text] [Related]
33. Bitter Melon ( Sur S; Ray RB Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914 [TBL] [Abstract][Full Text] [Related]
35. Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats. Bai J; Zhu Y; Dong Y J Ethnopharmacol; 2016 Dec; 194():717-726. PubMed ID: 27751827 [TBL] [Abstract][Full Text] [Related]